Comparison of Amyloid PET and CSF Biomarkers in the Evaluation of Dementia

被引：0
|
作者：
Rabinovici, Gil [1 ]
Jagust, William [2 ]
Ghosh, Pia [1 ]
Madison, Cindee [2 ]
Karydas, Anna [1 ]
Boxer, Adam [1 ]
Trojanowski, John [3 ]
Miller, Bruce [1 ]
Shaw, Leslie [3 ]
Rosen, Howard [1 ]
机构：
[1] UCSF, Memory & Aging Ctr, Dept Neurol, San Francisco, CA USA
[2] UC Berkeley, Helen Wills Neurosci Inst, Oakland, CA USA
[3] Univ Penn, Ctr Neurodegenerat Res, Philadelphia, PA 19104 USA
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PD1004
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CSF Biomarkers and Amyloid PET in MCI
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (05) : 18N - 18N
  • [2] Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
    Palmqvist, Sebastian
    Zetterberg, Henrik
    Mattsson, Niklas
    Johansson, Per
    Minthon, Lennart
    Blennow, Kaj
    Olsson, Mattias
    Hansson, Oskar
    [J]. NEUROLOGY, 2015, 85 (14) : 1240 - 1249
  • [3] Comparison between amyloid-PET and CSF amyloid-β biomarkers in a clinical cohort with memory deficits
    Bouter, Caroline
    Vogelgsang, Jonathan
    Wiltfang, Jens
    [J]. CLINICA CHIMICA ACTA, 2019, 492 : 62 - 68
  • [4] Concordance between amyloid PET imaging and CSF biomarkers in clinical setting
    Marotta, G.
    Sacchi, L.
    Fumagalli, G. G.
    Pietroboni, A. M.
    Arighi, A.
    Ghezzi, L.
    Colombi, A.
    Carandini, T.
    Scarioni, M.
    Buffoni, F.
    Rognoni, M.
    Galimberti, D.
    Scarpini, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S519 - S519
  • [5] Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
    Reimand, Juhan
    Groot, Colin
    Teunissen, Charlotte E.
    Windhorst, Albert D.
    Boellaard, Ronald
    Barkhof, Frederik
    Nazarenko, Sergei
    van der Flier, Wiesje M.
    van Berckel, Bart N. M.
    Scheltens, Philip
    Ossenkoppele, Rik
    Bouwman, Femke
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (02) : 559 - 569
  • [6] Concordance between CSF biomarkers and amyloid PET imaging in clinical setting
    Sacchi, L.
    Fumagalli, G. G.
    Arighi, A.
    Mercurio, M.
    Fenoglio, C.
    Pietroboni, A. M.
    Ghezzi, L.
    Colombi, A.
    Carandini, T.
    Scarioni, M.
    Galimberti, D.
    Marotta, G.
    Scarpini, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 118 - 118
  • [7] Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
    de Wilde, Arno
    Reimand, Juhan
    Teunissen, Charlotte E.
    Zwan, Marissa
    Windhorst, Albert D.
    Boellaard, Ronald
    van der Flier, Wiesje M.
    Scheltens, Philip
    van Berckel, Bart N. M.
    Bouwman, Femke
    Ossenkoppele, Rik
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (01)
  • [8] CSF biomarkers in dementia
    Peters, O.
    Schipke, C. G.
    [J]. NERVENHEILKUNDE, 2013, 32 (10) : 733 - 736
  • [9] CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort
    Marco Spallazzi
    Federica Barocco
    Giovanni Michelini
    Paolo Immovilli
    Arens Taga
    Nicola Morelli
    Livia Ruffini
    Paolo Caffarra
    [J]. Acta Neurologica Belgica, 2019, 119 : 445 - 452
  • [10] Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
    Arno de Wilde
    Juhan Reimand
    Charlotte E. Teunissen
    Marissa Zwan
    Albert D. Windhorst
    Ronald Boellaard
    Wiesje M. van der Flier
    Philip Scheltens
    Bart N. M. van Berckel
    Femke Bouwman
    Rik Ossenkoppele
    [J]. Alzheimer's Research & Therapy, 11
12345